New puppy boosts morale, lowers stress among Birmingport first responders
Firefighters said stress on the mind and body is a big contributor to deadly cardiac events. To help lower this stress among first responders, the Birmingport Fire Department has brought a new member on board.
'It's hard to imagine him not being around, and it's only been a few months that I've had him,' Birmingport Fire Chief Wade Holley said.
Epi, short for Epinephrin, is a 6-month-old Boston Terrier who has already brought lots of smiles to Birmingport's firefighters. Holley adopted Epi, and he's quickly become the emotional support dog of the fire station.
'He's really become a tool for stress relief in the department,' Holley said. 'You have a bad call, you're having a bad day, all you have to do is come to the station and sit down on the recliner, and Epi's going to curl up next to you and lick you to death, and that just makes your day go better.'
Birmingport firefighters said their days have gotten better with Epi around.
'Morale has changed dramatically over the last couple of months,' said Birmingport firefighter Ryan Ross. 'This is a small area, small community, but our department seems to be growing and progressing in a positive direction.'
'We've actually had an increase of volunteers coming and hanging out at the station not because of me,' Holley said. 'It's because of Epi. They want to come hang out with Epi and when we get a call, we have more people here at the station to respond immediately.'
Brighton City Councilman Jerome McMullin charged with releasing video of double homicide during active investigation
Epi might not be the stereotypical fire house dog. But despite being small, he helps in a big way.
'More than 100 years ago, Dalmatians were used in the fire service to keep away animals in the bay when they used horses to pull some of the carriages and things like that,' Ross said. 'This is our Dalmatian. This is our firehouse dog.'
Epi's helping more than just the firefighters. Over the weekend, some kayakers capsized in Valley Creek in west Jefferson County. While the families waited at the department's fire station for their loved ones, Epi was there to comfort the children.
'When they came into the station, that family seemed pretty down, especially with the kids,' Ross said. 'They were kind of confused about what's going on and scared. It's a new environment. It's something new, and of course the dog was here. Bring Epi in, and it's just like that. You can definitely tell how the children seemed to react. They seemed to chill out little bit. They weren't so anxious.'
Because Epi was present for most of the basic emergency medical technician classes this spring, the Birmingport Fire Department considers him an honorary EMT.
'They know when you're sick. They know when you're scared. They know when you're anxious,' Ross said. 'They want to sit in your lap. They're a huge comfort. They can definitely lower your blood pressure and stress. For me, coming by and seeing Epi cheer others up that may be down or have something going on, that makes me feel good.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
22-07-2025
- Business Wire
Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)
CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the Centers for Medicare and Medicaid Services (CMS), through the MolDX program, has issued preliminary gapfill payment rates of $350 for Epi+Gen CHD™ and $684.76 for PrecisionCHD™. A 'gapfill' payment rate means that pricing is determined by each Medicare contractor, including MolDX, based on cost data from Cardio Diagnostics. These preliminary payment rates, proposed as part of the calendar year 2025 gapfill pricing process, are expected to be finalized later this year and will be effective for claims with dates of service on or after January 1, 2025. The proposed rates represent a significant positive development in the Company's efforts to expand access to its advanced cardiovascular testing for Medicare beneficiaries. 'We view this as a critical step toward expanding timely access and improving care for Medicare patients' said Meesha Dogan, PhD., CEO and Co-Founder of Cardio Diagnostics. 'Many Medicare beneficiaries, who are at elevated risk for coronary heart disease, go undetected and undertreated, often resulting in avoidable heart attacks, hospitalizations, and poor outcomes.' Cardio Diagnostics clarified during a recent meeting with MolDX that initial public documentation had inadvertently transposed the pricing between the two tests, and MolDX confirmed the correct association of the proposed payment rates to their respective tests. Addressing the Leading Cause of Death Cardiovascular disease remains the leading cause of death in the United States, particularly among Americans aged 65 and older. In 2022 alone, over 700,000 Americans died from heart disease, with coronary heart disease (CHD) accounting for more than 370,000 deaths. PrecisionCHD™ is a groundbreaking AI-powered test designed to aid in the diagnosis of CHD by analyzing both genetic and epigenetic markers. Meanwhile, Epi+Gen CHD™ provides insight into a patient's three-year risk for a CHD event, such as a heart attack. Both tests are performed from a simple blood draw, enabling scalable, accessible, and non-invasive cardiovascular assessment. Both tests received dedicated CPT Proprietary Laboratory Analysis (PLA) codes from the American Medical Association, 0439U for Epi+Gen CHD and 0440U for PrecisionCHD, that were effective on April 1, 2024. About Cardio Diagnostics Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The Company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine ('Core Technology') for cardiovascular disease to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease. For more information, please visit Forward-Looking Statements Certain statements and information included in this press release constitute 'forward-looking statements' within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases 'will', 'will likely result,' 'expected to,' 'will continue,' 'anticipated,' 'estimate,' 'projected,' 'intend,' 'goal,' or similar expressions are intended to identify 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, economic conditions, and dependence on results as discussed in the Annual Report on Form 10-K for the period ended December 31, 2024, under the heading 'Risk Factors' in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.
Medscape
17-07-2025
- Medscape
Rapid Review: Exocrine Pancreatic Insufficiency (EPI)
While historically underdiagnosed, increased awareness and improved diagnostic strategies for exocrine pancreatic insufficiency (EPI) have helped identify patients earlier, thus facilitating more effective management. However, despite advances in treatment modalities, patient outcomes vary considerably due to differences in individual physiology, adherence to treatment regimens, and concurrent health issues. Efforts to address these disparities focus increasingly on personalized medicine, emphasizing the integration of tailored nutritional strategies, patient education, and multidisciplinary care teams to improve patient outcomes comprehensively. Recent guidelines advocate for the prompt initiation of PERT as soon as EPI is diagnosed. Additionally, a multidisciplinary evaluation to assess further nutritional needs and coordination with endocrinologists for the evaluation and treatment of diabetes is also warranted. Untreated EPI can impair growth in pediatric patients, and is associated with a number of clinical symptoms including gastrointestinal effects, osteoporosis, sarcopenia, coagulopathy, neuropathy, and other sequelae related to nutrient deficiency. Although other tests can help in certain cases, EPI can be sufficiently diagnosed with a validated pancreatic function test, and awaiting further confirmatory information such as severe clinical symptoms, positive imaging findings, or documented nutritional deficiencies is not necessary. Learn more about management approaches for EPI. Digestion of fat is a central function of the pancreas, with dysfunction causing deficiency in fat soluble essential vitamins. Although the American Gastroenterological Association (AGA) guidelines recommend a low-to-moderate-fat diet for patients with EPI, they specifically recommend against a very-low fat diet as this can exacerbate deficiencies. Further, meals should be more frequent and smaller, and vitamin and mineral deficiencies should be screened for at diagnosis and annually thereafter. Learn more about diet in EPI. Although fecal fat testing is considered the gold-standard for assessing fecal fat malabsorption, which is a measure of pancreatic dysfunction, it has low specificity for EPI since other diseases can present with steatorrhea. The AGA notes that fecal fat testing is 'rarely needed', it is burdensome (requires a 72 hour stool collection), and can only be done when the patient is on a high-fat diet. Additionally, fecal fat tests are known to be susceptible to false positive results in patients with diarrhea, which is a common symptom of EPI. The AGA recommends fecal elastase as the best test for initial screening, although fecal fat may be useful in cases with inconclusive clinical features and imaging. Learn more about pancreatic function tests. The AGA Clinical Practice Update emphasizes that while cross-sectional imaging — such as CT, MRI, and endoscopic ultrasound — cannot directly diagnose EPI, it plays an essential role in identifying benign and malignant pancreatic diseases that may underlie or contribute to exocrine insufficiency. Imaging can reveal features like advanced calcific chronic pancreatitis, ductal changes, or significant pancreatic atrophy, which correlate with the presence of EPI. However, moderate changes in imaging do not reliably correlate with EPI, and normal imaging is associated with its absence. Although advanced tools like secretin-enhanced MRCP or elastography show promise, current imaging lacks sufficient accuracy to predict EPI on its own. Therefore, imaging should be viewed as a complementary tool in the diagnostic process, providing context about pancreatic structure rather than functional status. For dosing of PERT, the AGA has specific recommendations dependent on fat content of meals and current symptom profile, not imaging findings. Learn more about the multidisciplinary workup for patients with EPI. The latest AGA guidelines emphasize the importance of regular and comprehensive monitoring of nutritional status in all patients with EPI, including regular DEXA scans every 1-2 years. Additionally, baseline and periodic assessment of anthropometric indicators, biochemical markers, and clinical evaluation should be established. DEXA scanning can help to detect sarcopenia, which is possible even in patients with obesity. It can be caused by the nutritional deficits seen in patients with EPI and is associated with increased adverse outcomes and physical disability. The AGA also notes that other muscle mass and function tests can be considered as well. Learn more about the management of patients with EPI.
New York Post
14-07-2025
- New York Post
Airplane passenger's life-saving allergy request sparks harsh backlash
This tentative traveler drove fellow flyers nuts. After boarding an easyJet flight, content creator Dan Kelly, who posts on TikTok as @_maycontain, filmed his interaction with a flight attendant, whom he immediately pulled aside to note his severe nut allergies. Though the airline banned the sale of peanuts on its flights several years back, and asks passengers not to bring snacks containing nuts onboard, Kelly often lets cabin crews know about his allergy, which he claims can be triggered by nut particles in the air. Advertisement 3 Kelly suggests passengers with severe allergies pack several Epi-Pens that can remain handy whenever. Instagram/@_maycontain The prudent passenger also asked if the cabin crew could make an announcement to other travellers, letting them know that this flight would have to be nut-free for his own safety. The friendly flight attendant asked the TikTokker where his seat was, and inquired whether or not he had any EpiPens, before sending him on his way, worry-free. Advertisement 'I love it when [flight attendants] understand straight away,' the content creator wrote in the comments, praising the steward for his pragmatism and no-nonsense attitude. @_maycontain Surely people can go without nuts for a few hours if it could save someone's life! Honestly, I don't understand why some people still don't take food allergies seriously. If it were you or your child living with a life-threatening allergy, you'd hope others would show a bit more empathy and recognise just how serious it really is! ✈️If you travelling or going abroad with a food allergy, make sure to check the 🔗 in my bio #allergy #foodallergy #allergies #easyjet ♬ original sound – May Contain The content creator's page is dedicated to bringing awareness and understanding to allergy-related issues. Typically, his videos range from demonstrating proper Epi-Pen use to offering up his experience on dating while living with a serious allergy. Advertisement 'I've had a severe nut allergy since I was 5. It impacts my daily life constantly; living with the fear of a reaction is exhausting, and it's even more intense when traveling abroad,' Kelly told Newsweek. 'Every time I fly, I ask the airline to make an announcement just in case someone nearby starts eating nuts,' Kelly added as even minor exposure — through air particles or surface contact — can trigger a reaction. 'If someone eats nuts, doesn't wash their hands, then touches me, that could trigger it.' 3 Though many flight attendants don't mind making the announcements, airlines also typically state that they cannot guarantee a fully nut-free environment. SPS Media – Though many were sympathetic to Kelly's fear of mid-flight anaphylaxis — which could be triggered by touching or inhaling nearby nut residue — others weren't so willing to give up their salty snacks. Advertisement 'Your ticket should cost more if you being on the plane changes the rules for everyone else against their consent,' argued one harsh commenter, while another said, 'Since when has an entire group accommodating to a single individual become the norm? One person shouldn't dictate what a plane load of people can and cannot eat.' 3 The TikTokker was flying from Pisa to London. TikTok/@_maycontain While some commenters advised Kelly to wear gloves and a mask for additional protection, one user offered an entirely different — and somewhat ruthless — suggestion. 'It's a choice to fly, you don't have to. Why should everyone else have to worry about you? Just because you want to get on a plane,' criticized one viewer. 'I booked this ticket strictly to eat plane peanuts, it's not fair,' quipped a dry-witted commenter, referring to the wave of backlash Kelly received — which several other users also dubbed 'ridiculous.' 'Imagine how annoying it would be to have to emergency land in the middle of nowhere because someone couldn't resist a granola bar and it nearly killed another person,' reasoned another viewer. Advertisement While allergies are lifelong conditions for many, new research surrounding the affliction has proven that, in some instances, it is possible to cure a nut allergy. However, until these procedures become more commonplace, Kelly simply asks that his fellow passengers opt for an alternative snack while stuck in a pressurized cabin miles above the ground.
